Latest chemotherapy Stories
September is Blood Cancer Awareness Month, making it the perfect time to announce next year’s law school scholarship for survivors or family members affected by blood cancers. San
Data presented at the Association of Pediatric Hematology/Oncology Nurses (APHON) Annual Conference in Portland, OR September 4-6 highlights the effectiveness of the ChemoClave closed system transfer
Doctors at Atlantic NeuroSurgical Specialists (ANS) have added a new and innovative form of therapy to their treatment arsenal in the battle against glioblastoma multiforme (GBM).
New Book reveals the humor-filled accounts of one woman going through chemotherapy. Harrisburg, Penn.
Doctors in Italy have linked an electrolyte imbalance with shorter survival times in people on chemotherapy for malignant pleural mesothelioma. (PRWEB) August
NovoTTF™-100A System Offers Novel, Non-Invasive Treatment in Fight Against an Aggressive Type of Brain Cancer Morristown,NJ (PRWEB) August 27, 2014
DelMar Is Advancing Clinical Trials With VAL-083 As A New Chemotherapy For Refractory Glioblastoma Multiforme VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.
10-Member Team to Focus on Increasing Nurse Awareness of Occupational Hazards and Safety PORT WASHINGTON, New York, August 26, 2014 /PRNewswire/ -- Equashield (www.equashield.com
TROY, Mich., Aug. 25, 2014 /PRNewswire/ -- Bianchi Public Relations, Inc.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.